Page last updated: 2024-08-24

telmisartan and Cholangitis, Sclerosing

telmisartan has been researched along with Cholangitis, Sclerosing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Demir, M; Dienes, HP; Goeser, T; Hunt, H; Mende, S; Nierhoff, D; Odenthal, M; Pryymachuck, G; Quasdorff, M; Schulte, S; Steffen, HM; Strack, I; Töx, U	1

Other Studies

1 other study(ies) available for telmisartan and Cholangitis, Sclerosing

Article	Year
Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model. Digestive diseases and sciences, 2013, Volume: 58, Issue:5 Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Benzimidazoles; Benzoates; Bile Ducts; Cholangitis, Sclerosing; Collagen Type I; Collagen Type I, alpha 1 Chain; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Liver; Mice; Mice, Inbred BALB C; Mice, Knockout; Myofibroblasts; Propranolol; Receptor, Angiotensin, Type 1; RNA, Messenger; Telmisartan	2013

Article

Year

Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.

Digestive diseases and sciences, 2013, Volume: 58, Issue:5

Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Benzimidazoles; Benzoates; Bile Ducts; Cholangitis, Sclerosing; Collagen Type I; Collagen Type I, alpha 1 Chain; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Liver; Mice; Mice, Inbred BALB C; Mice, Knockout; Myofibroblasts; Propranolol; Receptor, Angiotensin, Type 1; RNA, Messenger; Telmisartan

2013